Pfizer's GAAP net income for 6 months of 2021 was $10.475 billion, up 52.7% from $6.86 billion in the previous year. Revenues increased 68.2% to $33.559 billion from $19.947 billion a year earlier.
Pfizer's GAAP net income for 6 months of 2021 was $10.475 billion, up 52.7% from $6.86 billion in the previous year. Revenues increased 68.2% to $33.559 billion from $19.947 billion a year earlier. 
investors.pfizer.com
English (US) 